|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $65,485,187 | $140,205,728 | $81,906,218 | $102,142,554 | $72,603,614 | $66,500,339 | $81,832,153 |
| Streptomycins & their derivs.; salts thereof | $106,951 | $43,566 | $42,711 | $96,671 | $1,535,701 | $443,049 | $734,996 |
| Tetracyclines & their derivs.; salts thereof | $42,645,368 | $19,119,862 | $20,669,877 | $40,868,995 | $5,064,928 | $5,309,016 | $8,593,706 |
| Chloramphenicol & its derivs.; salts thereof | $15,741 | $639,860 | $31,763 | $15,323 | $24,134 | $159,915 | $361,082 |
| Erythromycin & its derivs.; salts thereof | $3,919,536 | $1,138,501 | $24,346,393 | $18,462,123 | $4,020 | $204,657 | $784,574 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $160,457,906 | $196,358,947 | $171,601,569 | $149,766,960 | $153,908,773 | $139,240,535 | $154,085,046 |
| Total | $272,630,689 | $357,506,464 | $298,598,531 | $311,352,626 | $233,141,170 | $211,857,511 | $246,391,557 |
|
|
